Education and Health Notices




1226 NEW ZEALAND GAZETTE, No. 48 25 MAY 2006

Minister of Education on behalf of Her Majesty the Queen,
acting through the Senior Manager, National Operations,
Ministry of Education, pursuant to delegated authority, and
the proprietors of the following schools:
St Mary’s College, Wellington.
St Catherine’s College, Kilbirnie, Wellington.
The said supplementary integration agreements were executed
on 10 May 2006.

Copies of the supplementary integration agreements are
available for inspection without charge by any member of
the public at the regional office of the Ministry of Education,
65 Waterloo Road, Lower Hutt, Wellington.
Dated at Wellington this 15th day of May 2006.
GRAEME MARSHALL, Acting Senior Manager, National
Operations.

go3367


Health

Medicines Act 1981

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of
the new medicines set out in the Schedule hereto:

Schedule

Product: Arrow – Terbinafine
Active Ingredient: Terbinafine hydrochloride 281.25mg equivalent to 250mg terbinafine
Dosage Form: Tablet
New Zealand Sponsor: Arrow Pharmaceuticals (NZ) Limited
Manufacturers: Arrow Pharm (Malta) Limited, Hal Far, Malta
Faco Ilaclari AS, Levant, Istanbul, Turkey

Product: Flomaxtra
Active Ingredient: Tamsulosin hydrochloride 400µg
Dosage Form: Modified release tablet
New Zealand Sponsor: CSL New Zealand Limited
Manufacturer: Astellas Pharma Europe B.V., Meppel, The Netherlands

Product: m-Fluconazole
Active Ingredient: Fluconazole 2mg/mL
Dosage Form: Solution for infusion
New Zealand Sponsor: Multichem NZ Limited
Manufacturer: Pharmathen SA, Pallini, Attikis, Greece

Product: Strepsils Lemon Sugar Free
Active Ingredients: Amylmetacresol 0.6mg
Dichlorobenzyl alcohol 1.2mg
Dosage Form: Lozenge
New Zealand Sponsor: Reckitt Benckiser (New Zealand) Limited
Manufacturer: The Boots Company Plc., Beeston, Nottingham, Nottinghamshire, United Kingdom

Product: Sudafed PE Phenylephrine Nasal Decongestant (Pharmacy Only)
Active Ingredient: Phenylephrine hydrochloride 10mg equivalent to 8.2mg phenylephrine
Dosage Form: Tablet
New Zealand Sponsor: Pfizer Consumer Healthcare Div. of Pfizer New Zealand Limited
Manufacturer: Pfizer Australia Pty Limited, West Ryde, New South Wales, Australia

Product: Atacand
Active Ingredient: Candesartan cilexetil 32mg
Dosage Form: Tablet
New Zealand Sponsor: AstraZeneca Limited
Manufacturer: AstraZeneca AB, Snackviken, Sodertalje, Sweden

Dated this 17th day of May 2006.

KAREN MITCHELL, Acting Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health
on 6 July 2001).

go3437



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2006, No 48


Gazette.govt.nz PDF NZ Gazette 2006, No 48





✨ LLM interpretation of page content

🎓 Supplementary Integration Agreements under Private Schools Conditional Integration Act 1975

🎓 Education, Culture & Science
15 May 2006
Supplementary Integration Agreements, Private Schools, Wellington
  • GRAEME MARSHALL, Acting Senior Manager, National Operations

🏥 Consent to the Distribution of New Medicines under the Medicines Act 1981

🏥 Health & Social Welfare
17 May 2006
Medicines Act 1981, New Medicines, Consent, Distribution
  • KAREN MITCHELL, Acting Deputy Director-General, Public Health